Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

FDA approves once-monthly Sublocade to treat opioid use disorder

Dec. 1, 2017

FDA accepts, grants priority review to lofexidine NDA

Nov. 22, 2017

Orexo's Zubsolv approved for opioid dependence in Europe

Nov. 21, 2017

OX1 receptor antagonist C4X_3256 demonstrates efficacy in nicotine dependence rat model

Nov. 15, 2017

FDA committee recommends approval of Braeburn Pharmaceuticals' CAM-2038 for opioid use disorder

Nov. 2, 2017

FDA awards orphan drug status to Pluristem's PLX-R18 for ARS

Oct. 20, 2017

Otsuka submits NDA for nalmefene in Japan

Oct. 19, 2017

Anti-ALDH2 gene therapy could discourage alcohol intake

Oct. 11, 2017

NIH grant supports exploration of NVP-015 for use against chemical threats

Oct. 5, 2017

Emergent BioSolutions completes acquisition of raxibacumab from GSK

Oct. 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...